A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics

Simple item page
dc.citation.firstpage3319
dc.citation.issueNumber10
dc.citation.journalTitleBiomaterials
dc.citation.lastpage3330
dc.citation.volumeNumber35
dc.contributor.authorXu, Xian
dc.contributor.authorSabanayagam, Chandran R.
dc.contributor.authorHarrington, Daniel Anton
dc.contributor.authorFarach-Carson, Mary C.
dc.contributor.authorJia, Xinqiao
dc.date.accessioned2015-03-16T16:56:10Z
dc.date.available2015-03-16T16:56:10Z
dc.date.issued2014
dc.description.abstractThree-dimensional (3D) tissue-engineered tumor models have the potential to bridge the gap between monolayer cultures and patient-derived xenografts for the testing of nanoparticle (NP)-based cancer therapeutics. In this study, a hydrogel-derived prostate cancer (PCa) model was developed for the in vitro evaluation of doxorubicin (Dox)-loaded polymer NPs (Dox-NPs). The hydrogels were synthesized using chemically modified hyaluronic acid (HA) carrying acrylate groups (HA-AC) or reactive thiols (HA-SH). The crosslinked hydrogel networks exhibited an estimated pore size of 70–100 nm, similar to the spacing of the extracellular matrices (ECM) surrounding tumor tissues. LNCaP PCa cells entrapped in the HA matrices formed distinct tumor-like multicellular aggregates with an average diameter of 50 μm after 7 days of culture. Compared to cells grown on two-dimensional (2D) tissue culture plates, cells from the engineered tumoroids expressed significantly higher levels of multidrug resistance (MDR) proteins, including multidrug resistance protein 1 (MRP1) and lung resistance-related protein (LRP), both at the mRNA and the protein levels. Separately, Dox-NPs with an average diameter of 54 ± 1 nm were prepared from amphiphilic block copolymers based on poly(ethylene glycol) (PEG) and poly(ε-caprolactone) (PCL) bearing pendant cyclic ketals. Dox-NPs were able to diffuse through the hydrogel matrices, penetrate into the tumoroid and be internalized by LNCaP PCa cells through caveolae-mediated endocytosis and macropinocytosis pathways. Compared to 2D cultures, LNCaP PCa cells cultured as multicellular aggregates in HA hydrogel were more resistant to Dox and Dox-NPs treatments. Moreover, the NP-based Dox formulation could bypass the drug efflux function of MRP1, thereby partially reversing the resistance to free Dox in 3D cultures. Overall, the engineered tumor model has the potential to provide predictable results on the efficacy of NP-based cancer therapeutics.
dc.identifier.citationXu, Xian, Sabanayagam, Chandran R., Harrington, Daniel Anton, et al.. "A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics." <i>Biomaterials,</i> 35, no. 10 (2014) Elsevier: 3319-3330. http://dx.doi.org/10.1016/j.biomaterials.2013.12.080.
dc.identifier.doihttp://dx.doi.org/10.1016/j.biomaterials.2013.12.080
dc.identifier.urihttps://hdl.handle.net/1911/79350
dc.language.isoeng
dc.publisherElsevier
dc.rightsThis is an author's peer-reviewed final manuscript, as accepted by the publisher. The published article is copyrighted by Elsevier.
dc.subject.keywordhyaluronic acid
dc.subject.keywordhydrogel
dc.subject.keyword3D tumor model
dc.subject.keywordnanoparticles
dc.subject.keywordcancer therapeutics
dc.subject.keyworddrug resistance
dc.titleA hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics
dc.typeJournal article
dc.type.dcmiText
dc.type.publicationpost-print
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
nihms-552899.pdf
Size:
4.58 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Faculty Publications
Biochemistry and Cell Biology Publications